Business Description
Coherus BioSciences Inc
NAICS : 541714
SIC : 2836
ISIN : US19249H1032
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.36 | |||||
Equity-to-Asset | -0.17 | |||||
Debt-to-Equity | -3.07 | |||||
Debt-to-EBITDA | 7.24 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -3 | |||||
Beneish M-Score | -3.16 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -21.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 50.21 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.97 | |||||
9-Day RSI | 48.73 | |||||
14-Day RSI | 53.33 | |||||
6-1 Month Momentum % | -33.13 | |||||
12-1 Month Momentum % | -46.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 130.66 | |||||
Days Sales Outstanding | 264.81 | |||||
Days Payable | 90.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.7 | |||||
Shareholder Yield % | 60.7 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.71 | |||||
Operating Margin % | -45.45 | |||||
Net Margin % | -0.15 | |||||
FCF Margin % | -20.38 | |||||
ROA % | -0.07 | |||||
ROIC % | -63.8 | |||||
ROC (Joel Greenblatt) % | 119.17 | |||||
ROCE % | 12.41 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 16.9 | |||||
PS Ratio | 0.56 | |||||
EV-to-EBIT | 10.81 | |||||
EV-to-Forward-EBIT | 5.61 | |||||
EV-to-EBITDA | 9.27 | |||||
EV-to-Forward-EBITDA | 5.54 | |||||
EV-to-Revenue | 1.14 | |||||
EV-to-Forward-Revenue | 1.96 | |||||
EV-to-FCF | -5.43 | |||||
Earnings Yield (Greenblatt) % | 9.25 | |||||
FCF Yield % | -37.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CHRS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Coherus BioSciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 304.34 | ||
EPS (TTM) ($) | -0.08 | ||
Beta | 1.09 | ||
Volatility % | 107.54 | ||
14-Day RSI | 53.33 | ||
14-Day ATR ($) | 0.178522 | ||
20-Day SMA ($) | 1.5355 | ||
12-1 Month Momentum % | -46.04 | ||
52-Week Range ($) | 0.6603 - 3.7 | ||
Shares Outstanding (Mil) | 115.21 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Coherus BioSciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Coherus BioSciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Coherus BioSciences Inc Frequently Asked Questions
What is Coherus BioSciences Inc(CHRS)'s stock price today?
When is next earnings date of Coherus BioSciences Inc(CHRS)?
Does Coherus BioSciences Inc(CHRS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |